The latest cancer drugs news
Browsing: Cancer Drug News
New insights on a potentially serious side effect of the cancer drug alpelisib
New research has uncovered elevated rates of high blood sugar, or hyperglycemia, among patients with…
Better together against cancer
To give cancer treatments the greatest possible chance of success, patients are often treated with…
Uterine cancer drug gets fast-track approval
A new drug – tulmimetostat – has been given fast-track approval by the US Food and Drug…
Could a cancer drug hold the key to a HIV cure?
An existing blood cancer drug has shown promise in killing ‘silent’ HIV cells and delaying…
Scientists find evidence of unintended impacts from anti-cancer drugs
With around 90% of drugs failing to make it to market, the potential for improving…
European Commission approves reduced dosing frequency of teclistamab for multiple myeloma
The European Commission (EC) has granted the approval of a type II variation application for…
Blood cancer therapy granted accelerated FDA approval
The US Food and Drug Administration (FDA) has given the green light to Elrexfio™ (elranatamab-bcmm),…
Use of metformin Investigated in prostate cancer treatment
Patients with localised prostate cancer have a good chance of survival, but mortality rates among…
FDA approves melphalan as a liver-directed treatment for uveal melanoma
On August 14, 2023, the Food and Drug Administration approved HEPZATO KIT (melphalan for Injection/Hepatic…
Some costly cancer drugs can have unclear patient benefits
Cancer drugs are a dominant area in the pharmaceutical industry, constantly developing and launching new…